Skip to content

Individual differences in the positive outcome from adolescent ketamine treatment in a female mouse model of anorexia nervosa involve drebrin A at excitatory synapses of the medial prefrontal cortex

Rose Temizer, Yi‐Wen Chen, Chiye Aoki

Synapse September 19, 2022 DOI: 10.1002/syn.22253 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Animal model study Peer reviewed
Population Adolescent female mice in an activity-based anorexia model
Intervention Ketamine
Dose 30 mg/kg and 3 mg/kg
Topics Esketamine Ketamine
Key points A single 30 mg/kg ketamine injection, but not 3 mg/kg, produced lasting reductions in anorexia-like symptoms in adolescent female mice, with individual variability in response. Electron microscopy linked the higher dose to greater excitatory synapse density on GABAergic interneurons and a higher proportion of drebrin A-positive excitatory synapses on pyramidal neurons and interneurons, which the authors interpret as evidence of ketamine-induced homeostatic plasticity involving drebrin A.

Abstract

Anorexia nervosa (AN) is a mental illness with the highest rates of mortality and relapse, and no approved pharmacological treatment. Using an animal model of AN, called activity‐based anorexia (ABA), we showed earlier that a single intraperitoneal injection of ketamine at a dose of 30 mg/kg (30mgKET), but not 3 mg/kg (3mgKET), has a long‐lasting effect upon adolescent females of ameliorating anorexia‐like symptoms through the following changes: enhanced food consumption and body weight; reduced running and anxiety‐like behavior. However, there were also individual differences in the drug's efficacy. We hypothesized that individual differences in ketamine's ameliorative effects involve drebrin A, an F‐actin‐binding protein known to be required for the activity‐dependent trafficking of NMDA receptors (NMDARs). We tested this hypothesis by electron microscopic quantifications of drebrin A immunoreactivity at excitatory synapses of pyramidal neurons (PN) and GABAergic interneurons (GABA‐IN) in deep layer 1 of prefrontal cortex (PFC) of these mice. Results reveal that (1) the areal density of excitatory synapses on GABA‐IN is greater for the 30mgKET group than the 3mgKET group; (2) the proportion of drebrin A+ excitatory synapses is greater for both PN and GABA‐IN of 30mgKET than 3mgKET group. Correlation analyses with behavioral measurements revealed that (3) 30mgKET's protection is associated with reduced levels of drebrin A in the cytoplasm of GABA‐IN and higher levels at extrasynaptic membranous sites of PN and GABA‐IN; (5) altogether pointing to 30mgKET‐induced homeostatic plasticity that engages drebrin A at excitatory synapses of both PN and GABA‐IN.

Comparable studies

Other preclinical and animal studies on ketamine, most cited first.

Citations in the library

Explore topics